People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medcura, Inc. | — | Biotechnology | Series B | $40.9M | $145.0M | 2020 |
| Immusoft Corp | — | Other | Series A | $24.0M | $21.5M | 2018 |
| Chumby Industries Inc | — | Other | Series A | $20.3M | $22.7M | 2009 |
Rich Vincent at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rich Vincent on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| RICHARD LEVANDOV | 1 | 20 |
| Anthony Sun | 1 | 8 |
| Marc Sokol | 1 | 7 |
| Stephen Tomlin | 1 | 6 |
| Sean Ainsworth | 1 | 5 |
| Eric Garcia | 1 | 3 |
| Matthew Scholz | 1 | 3 |
| Tasha Seitz | 1 | 3 |
| Julia Moore | 1 | 3 |
| JIM BUCK | 1 | 2 |
| Larry Tiffany | 1 | 2 |
| Derrick Oien | 1 | 2 |
| Bruce Worman | 1 | 2 |
| Wendell King | 1 | 1 |
| Scott McIvor | 1 | 1 |
| Eric Herbig | 1 | 1 |
| Dave Morgan | 1 | 1 |
| Richard Chin, M.D. | 1 | 1 |
| Mark Ahn, Ph.D. | 1 | 1 |
| Abbas Ardehali, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.